Study finds indoor asthma triggers such as smoking, poor ventilation, and mould are strongly linked to worse symptoms and daily limitations.

The approval makes Dupixent the first FDA-approved therapy for allergic fungal rhinosinusitis, supported by Phase III data showing significant improvements in sinus opacification, nasal symptoms, and ...

Most folks in South Georgia know what it feels like to get a little winded, maybe from chasing kids around the yard, hauling feed, or hurrying across a parking lot […] ...

Changes of season can be refreshing, but when it comes to your lungs, they can pose unseen dangers. With increased cases of ...

Children with multiple nut allergies experienced significant increases in the amounts of allergens they could tolerate with ...

AFTER 55 days of cold, wet and downright miserable weather, most Brits will be thrilled to see warmer days finally heading our way. But as temperatures climb to a blissful 17C in some parts of the ...

New Delhi, February 24, 3036(ANI): On 23.02.2026 at about 5:55 PM, a PCR call was received at PS Mayur Vihar regarding an unconscious person inside a vehicle parked at Star City Mall, Mayur Vihar. On ...

Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitisApproval in adults and ...

A simple mistake during certain renovations can lead to injury, fines, or major damage. Find out what you shouldn't tackle ...

If your skin feels tight, your lips are cracking, or your home feels uncomfortably dry, it might be worth investing in a ...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...